Blueshift Asset Management, LLC Axsome Therapeutics, Inc. Transaction History

Blueshift Asset Management, LLC

  • $293 Million
  • Q2 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2023

May 12, 2023
BUY
$58.39 - $75.0 $219,721 - $282,225
3,763 New
3,763 $232,000
Q3 2022

Nov 14, 2022
BUY
$36.06 - $69.85 $174,314 - $337,654
4,834 New
4,834 $216,000
Q3 2019

Nov 12, 2019
SELL
$20.24 - $29.16 $638,450 - $919,823
-31,544 Closed
0 $0
Q2 2019

Aug 14, 2019
BUY
$13.46 - $25.75 $424,582 - $812,258
31,544 New
31,544 $812,000

Others Institutions Holding AXSM

# of Institutions
288
Shares Held
40.4M
Call Options Held
365K
Put Options Held
428K
View Full List

About Axsome Therapeutics, Inc.

AXSM Quotes by TradingView
  • Ticker AXSM
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 42,878,000
  • Market Cap $3.85B
  • Description
  • Axsome Therapeutics, Inc., a biopharmaceutical company, engages in the development of novel therapies for central nervous system (CNS) disorders in the United States. The company's product pipeline includes AXS-05, a therapeutic for the treatment of major depressive disorder and resistant depression disorders; and that is in the Phase III clinic...
More about AXSM
Track This Portfolio

Track Blueshift Asset Management, LLC Portfolio

Follow Blueshift Asset Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Blueshift Asset Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Blueshift Asset Management, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email